Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | IDO1 | P14902 | 1/20 | 0.31 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.31 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21358255 | 0.84 | CYP4F2 (0.33) | CYP4F2CYP4A11 | |
| SCHEMBL17062073 | 0.78 | IDO1 (0.33) | IDO1CYP3A4 | |
| SCHEMBL15517004 | 0.74 | IDO1 (0.31) | IDO1CYP3A4 | |
| SCHEMBL22085844 | 0.74 | CYP4F2 (0.38) | TRPA1ALDH1A1TSHRIDO1CYP4F2 | |
| SCHEMBL25219828 | 0.74 | TRPA1 (0.32) | TRPA1ALDH1A1TSHR | |
| SCHEMBL23588139 | 0.74 | ACHE (0.42) | TSHRIDO1CYP4F2CYP4A11 | |
| SCHEMBL11590958 | 0.74 | HSD17B10 (0.50) | ALDH1A1TSHRCYP4F2CYP4A11CYP3A4 | |
| SCHEMBL17071829 | 0.74 | HTR2A (0.36) | TRPA1ALDH1A1IDO1 | |
| SCHEMBL29354626 | 0.73 | PIK3CA (0.44) | TRPA1ALDH1A1TSHRIDO1CYP4F2 | |
| SCHEMBL118390 | 0.73 | PIK3CA (0.44) | TRPA1ALDH1A1TSHRIDO1CYP4F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040152903-A1 | 6-chloro-3-pyridylmethylpropylamine derivatives, preparation process thereof and bactericides | KUREHA CORPORATION (JP) | 2004-08-05 | — | — | US | disclosed |
| EP-1375483-A1 | 6-CHLORO-3-PYRIDYLMETHYLPROPYLAMINE DERIVATIVES, PREPARATION PROCESS THEREOF AND BACTERICIDES | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 2004-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040152903-A1 | 6-chloro-3-pyridylmethylpropylamine derivatives, preparation process thereof and bactericides | PGLS, TLR6, UROD | TRPA1 1023/4885ALDH1A1 2464/4885TSHR 3142/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.